(株)カイオム・バイオサイエンスの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4583/E26096 | Chiome Bioscience Inc. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2012/10/05 | 日証協 | 210,300株 | -10.78% | 1,600株 | 0% | 272,702株 | -0.73% | 24,900株 | -58.29% |
| 2012/09/28 | 日証協 | 235,700株 | 0% | 0株 | -100% | 274,720株 | +0.11% | 59,702株 | +1958.69% |
| 2012/09/21 | 日証協 | 235,700株 | -0.97% | 20,400株 | +19.3% | 274,422株 | -1.4% | 2,900株 | +107.14% |
| 2012/09/14 | 日証協 | 238,000株 | +14.26% | 17,100株 | -67.24% | 278,322株 | +12.22% | 1,400株 | -97.62% |
| 2012/09/07 | 日証協 | 208,300株 | +29.94% | 52,200株 | -16.35% | 248,022株 | +35.37% | 58,900株 | -29.21% |
| 2012/08/31 | 日証協 | 160,300株 | +42.74% | 62,400株 | +39.29% | 183,222株 | +49.91% | 83,200株 | +134.37% |
| 2012/08/24 | 日証協 | 112,300株 | +15.06% | 44,800株 | 0% | 122,222株 | +23.06% | 35,500株 | +810.26% |
| 2012/08/17 | 日証協 | 97,600株 | -3.65% | 0株 | -100% | 99,322株 | +3.76% | 3,900株 | -65.18% |
| 2012/08/10 | 日証協 | 101,300株 | -6.29% | 4,500株 | +200% | 95,722株 | +8.01% | 11,200株 | -2.78% |
| 2012/08/03 | 日証協 | 108,100株 | -0.46% | 1,500株 | -95.28% | 88,622株 | +3.29% | 11,520株 | +284% |
| 2012/07/27 | 日証協 | 108,600株 | +4.42% | 31,800株 | +536% | 85,802株 | +3.62% | 3,000株 | +50% |
| 2012/07/20 | 日証協 | 104,000株 | +6.78% | 5,000株 | +78.57% | 82,802株 | +7.67% | 2,000株 | -81.82% |
| 2012/07/13 | 日証協 | 97,400株 | -8.29% | 2,800株 | -79.41% | 76,902株 | -1.54% | 11,000株 | -10.57% |
| 2012/07/06 | 日証協 | 106,200株 | +57.57% | 13,600株 | -64.4% | 78,102株 | +129.7% | 12,300株 | +1.65% |
| 2012/06/29 | 日証協 | 67,400株 | +4.5% | 38,200株 | +293.81% | 34,002株 | -36.57% | 12,100株 | -12.95% |
| 2012/06/22 | 日証協 | 64,500株 | -3.59% | 9,700株 | -42.26% | 53,602株 | +19.11% | 13,900株 | +47.87% |
| 2012/06/15 | 日証協 | 66,900株 | +28.65% | 16,800株 | -66.86% | 45,002株 | +18.11% | 9,400株 | -66.19% |
| 2012/06/08 | 日証協 | 52,000株 | +3366.67% | 50,700株 | +9999.99% | 38,102株 | +266.29% | 27,800株 | +1108.7% |
| 2012/06/01 | 日証協 | 1,500株 | 0% | 200株 | -86.67% | 10,402株 | +23.8% | 2,300株 | +21.05% |
※株式分割は考慮していませんのでご注意ください。
Page Top